InnovaRx Innova Health Strategies

L20.84

Intrinsic (allergic) eczema

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 19 never code together
L20.8code
Excludes2
  • circumscribed neurodermatitis (L28.0)L28.0
L20-L30block
Excludes2
  • chronic (childhood) granulomatous disease (D71-)D71-
  • dermatitis gangrenosa (L08.0)L08.0
  • dermatitis herpetiformis (L13.0)L13.0
  • dry skin dermatitis (L85.3)L85.3
  • factitial dermatitis (L98.1)L98.1
  • perioral dermatitis (L71.0)L71.0
  • radiation-related disorders of the skin and subcutaneous tissue (L55-L59)L55-L59
  • stasis dermatitis (I87.2)I87.2
L00-L99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • lipomelanotic reticulosis (I89.8)I89.8
  • neoplasms (C00-D49)C00-D49
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
  • systemic connective tissue disorders (M30-M36)M30-M36
  • viral warts (B07.-)B07.-

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 1
L20-L30block
Notes
  • In this block the terms dermatitis and eczema are used synonymously and interchangeably.
Index entries leading here 1
  • Eczema (acute) (chronic) (erythematous) (fissum) (rubrum) (squamous) L30.9
Alongside this code 4 same parent — L20.8
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
L20.8
Block
L20-L30
Siblings
4

Present FY2024–FY2027.